P. Verger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
P. Verger has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
B. Geoffroy
Institut of Protection and Nuclear Safety, Human Health Protection and Dosimetry Division, Laboratory of Epidemiology, France
2 shared publicationsB. Le Guen
EDF-GDF, Central Support Department for Health at Work, Biology and Radiotoxicology Laboratory, Saint-Denis, France
2 shared publicationsA. Aurengo
Department of Nuclear Medicine, Pitié-Salpêtrière Hospital, Paris, France
1 shared publication
Latest Publications
- 1 April 2001
- Published by SAGE Publications in Thyroid®
- Vol. 11 (4) , 353-360
Iodine Kinetics and Effectiveness of Stable Iodine Prophylaxis After Intake of Radioactive Iodine: A Review
Ingestion of potassium iodide (KI) offers effective protection against irradiation of the thyroid after accidental exposure to radioactive iodine. This prophylaxis aims at rapidly obtaining maximal thyroid protection without adverse effects. This article reviews studies on iodine kinetics in humans and on the efficacy of KI in protecting the thyroid. In adults with normal thyroid function, ingestion of 100 mg of iodide just before exposure to radioactive iodine blocks at least 95% of the thyroid dose. If exposure persists after iodide ingestion (100 mg), the percentage of averted dose may decrease significantly. Daily ingestion of a dose of 15 mg of KI would then maintain the thyroid blockade at a level above 90%. The efficacy of iodide and the occurrence of antithyroid effects also depend on external and individual factors such as dietary iodine intake, thyroid function, and age. The KI dosage regimen should be adjusted for age at exposure. For the fetus, the newborn, children, and adolescents, the risk of radiation-induced thyroid cancer in case of accidental exposure to radioactive iodine justifies KI prophylaxis, despite the risk of hypothyroidism, especially in newborns. For the elderly, the benefits of KI may be lower than the risk of iodine-induced hyperthyroidism.
- 1 April 2001
- Published by SAGE Publications in Thyroid®
- Vol. 11 (4) , 353-360
Iodine Kinetics and Effectiveness of Stable Iodine Prophylaxis After Intake of Radioactive Iodine: A Review
Ingestion of potassium iodide (KI) offers effective protection against irradiation of the thyroid after accidental exposure to radioactive iodine. This prophylaxis aims at rapidly obtaining maximal thyroid protection without adverse effects. This article reviews studies on iodine kinetics in humans and on the efficacy of KI in protecting the thyroid. In adults with normal thyroid function, ingestion of 100 mg of iodide just before exposure to radioactive iodine blocks at least 95% of the thyroid dose. If exposure persists after iodide ingestion (100 mg), the percentage of averted dose may decrease significantly. Daily ingestion of a dose of 15 mg of KI would then maintain the thyroid blockade at a level above 90%. The efficacy of iodide and the occurrence of antithyroid effects also depend on external and individual factors such as dietary iodine intake, thyroid function, and age. The KI dosage regimen should be adjusted for age at exposure. For the fetus, the newborn, children, and adolescents, the risk of radiation-induced thyroid cancer in case of accidental exposure to radioactive iodine justifies KI prophylaxis, despite the risk of hypothyroidism, especially in newborns. For the elderly, the benefits of KI may be lower than the risk of iodine-induced hyperthyroidism.
- Open Access
- 1 April 2000
- Published by EDP Sciences in Radioprotection
- Vol. 35 (2) , 151-174
Pharmacocinétique de l'iode : revue des connaissances utiles en radioprotection accidentelle
Lors d'une exposition à des rejets accidentels d'iodes radioactifs, la prise orale d'iode stable (iodure de potassium) permet de réduire ou d'éviter l'irradiation de la glande thyroïde. La posologie optimale est celle qui permet d'obtenir un blocage rapide et maximal du captage thyroïdien tout en évitant un dysfonctionnement thyroïdien. Cet article présente une revue des études sur la cinétique de l'iode dans l'organisme humain et l'efficacité du blocage thyroïdien par l'iode stable. Chez l'adulte euthyroïdien, la prise de 100 mg d'iodure juste avant l'exposition permet d'éviter 95 % ou plus de la dose à la thyroïde. Si l'exposition aux iodes radioactifs se prolonge après cette prise, le pourcentage de dose évitée à la thyroïde diminue de façon sensible. La répétition quotidienne de la prise d'iodure à une posologie plus faible (15 mg) permet alors de maintenir un blocage du captage supérieur à 90 %. L'efficacité du blocage et la survenue d'un dysfonctionnement thyroïdien dépendent de facteurs externes ou individuels : apports alimentaires d'iode, état fonctionnel de la thyroïde et âge. La posologie d'iode stable doit être adaptée en fonction de l'âge des individus au moment de l'exposition. Iodine kinetics and effectiveness of stable iodine prophylaxis after intake of radioiodine: a review. Ingestion of stable iodine (potassium iodide) offers an efficient protection against the irradiation of the thyroid when an accidental exposure to radioiodine occurs. This prophylaxis aims at obtaining a rapid and maximum thyroid protection without antithyroid effects. This article reviews studies on iodine kinetics in the human and on stable iodine effectiveness to protect the thyroid. In adults with a normal thyroid function, ingestion of 100 mg of iodide just before exposure to radioiodine allows a percentage of thyroid averted dose equal or greater than 95%. If the exposure persists after iodide ingestion (100 mg), the percentage of averted dose may decrease significantly. Repeated ingestion of daily amounts of 15 mg of stable iodine would then allow to maintain a 90% effectiveness. Iodide effectiveness and antithyroid effects also depend on external and individual factors such as iodine amounts in the diet, thyroid function and age. It is recommended to adapt the amount of ingested stable iodine according to age at the time of exposure.
- 1 April 2000
- Published by EDP Sciences in Radioprotection
- Vol. 35 (2) , 151-174
Open AccessPharmacocinétique de l'iode : revue des connaissances utiles en radioprotection accidentelle
Lors d'une exposition à des rejets accidentels d'iodes radioactifs, la prise orale d'iode stable (iodure de potassium) permet de réduire ou d'éviter l'irradiation de la glande thyroïde. La posologie optimale est celle qui permet d'obtenir un blocage rapide et maximal du captage thyroïdien tout en évitant un dysfonctionnement thyroïdien. Cet article présente une revue des études sur la cinétique de l'iode dans l'organisme humain et l'efficacité du blocage thyroïdien par l'iode stable. Chez l'adulte euthyroïdien, la prise de 100 mg d'iodure juste avant l'exposition permet d'éviter 95 % ou plus de la dose à la thyroïde. Si l'exposition aux iodes radioactifs se prolonge après cette prise, le pourcentage de dose évitée à la thyroïde diminue de façon sensible. La répétition quotidienne de la prise d'iodure à une posologie plus faible (15 mg) permet alors de maintenir un blocage du captage supérieur à 90 %. L'efficacité du blocage et la survenue d'un dysfonctionnement thyroïdien dépendent de facteurs externes ou individuels : apports alimentaires d'iode, état fonctionnel de la thyroïde et âge. La posologie d'iode stable doit être adaptée en fonction de l'âge des individus au moment de l'exposition. Iodine kinetics and effectiveness of stable iodine prophylaxis after intake of radioiodine: a review. Ingestion of stable iodine (potassium iodide) offers an efficient protection against the irradiation of the thyroid when an accidental exposure to radioiodine occurs. This prophylaxis aims at obtaining a rapid and maximum thyroid protection without antithyroid effects. This article reviews studies on iodine kinetics in the human and on stable iodine effectiveness to protect the thyroid. In adults with a normal thyroid function, ingestion of 100 mg of iodide just before exposure to radioiodine allows a percentage of thyroid averted dose equal or greater than 95%. If the exposure persists after iodide ingestion (100 mg), the percentage of averted dose may decrease significantly. Repeated ingestion of daily amounts of 15 mg of stable iodine would then allow to maintain a 90% effectiveness. Iodide effectiveness and antithyroid effects also depend on external and individual factors such as iodine amounts in the diet, thyroid function and age. It is recommended to adapt the amount of ingested stable iodine according to age at the time of exposure.